Problematic dichotomization of risk for Intensive Care Unit (ICU)-acquired invasive candidiasis: Results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients

Clinical Infectious Diseases

Volumn 63, Issue 11, 2016, Pages 1463-1469

  Playford, E Geoffrey ^a,b   Lipman, Jeffrey ^b,c   Jones, Michael ^d   Lau, Anna F ^e,m   Kabir, Masrura ^e   Chen, Sharon C A ^f,g   Marriott, Deborah J ^h   Seppelt, Ian ⁱ   Gottlieb, Thomas ^j   Cheung, Winston ^j   Iredell, Jonathan R ^e,k   McBryde, Emma S ^l,n   Sorrell, Tania C ^e,k  

^a PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j New Hampshire Dartmouth Psychiatric Research Center   (United States)

^k University of Sydney   (Australia)

^l UNIVERSITY OF MELBOURNE   (Australia)

^m NATIONAL INSTITUTES OF HEALTH   (United States)

ⁿ JAMES COOK UNIVERSITY   (Australia)

more..

Author keywords

Candidemia; Critical care; Invasive candidiasis; Prophylaxis; Risk prediction

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; PREDNISOLONE; TIGECYCLINE; ANTIFUNGAL AGENT;

ACCURACY; ADULT; ARTICLE; AUSTRALIAN; BLOOD TRANSFUSION; CANDIDA; CENTRAL VENOUS CATHETERIZATION; COHORT ANALYSIS; FEMALE; FUNGAL COLONIZATION; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; LENGTH OF STAY; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TOTAL PARENTERAL NUTRITION; URINE CULTURE; AGED; AUSTRALIA; CANDIDIASIS; CANDIDIASIS, INVASIVE; CLINICAL TRIAL; CRITICAL ILLNESS; CROSS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; THEORETICAL MODEL;

ADULT; AGED; ANTIFUNGAL AGENTS; AUSTRALIA; CANDIDA; CANDIDIASIS; CANDIDIASIS, INVASIVE; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 85014967893     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw610     Document Type: Article

References (29)

1. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43:25-31.
2. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49:3640-5.
3. Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteremia and fungemia. Clin Microbiol Rev 1997; 10:444-65.
4. Playford EG, Eggimann P, Calandra T. Antifungals in the ICU. Curr Opin Infect Dis 2008; 21:610-9.
5. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically-ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006; 57:628-38.
6. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702.
7. Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26:271-6.
8. Ostrosky-Zeichner L, Pappas PG, Shoham S, et al. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses 2011; 54:46-51.
9. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-8.
10. Leon C, Ruiz-Santana S, Saavedra S, et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34:730-7.
11. Harrison D, Muskett H, Harvey S, et al. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study. Health Technol Assess 2013; 17:1-156.
12. Playford EG, Lipman J, Kabir M, et al. Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 2009; 35:2141-5.
13. Paphitou NI, Ostrosky-Zeichner L, Rex J. Rules for identifiying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systemic use in antifungal prophylaxis trials. Med Mycol 2005; 43:235-43.
14. Lau A, Kabir M, Chen SC-A, et al. Candida colonisation as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol. J Clin Microbiol 2015; 53:1324-30.
15. Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
16. Cox DR. Regression models and life-tables. J R Stat Soc Ser B-Stat Methodol 1972; 34:187-220.
17. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KGM. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003; 56:441-7.
18. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model-building - application to the Cox regression-model. Stat Med 1992; 11:2093-109.
19. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982; 247:2543-6.
20. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PIFalagas ME. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011; 52:750-70.
21. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 2011; 49:665-70.
22. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 1997; 44:1413-8.
23. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S. Positive (1->3)-beta-D-glucan in blood components and release of (1->3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002; 42:1189-95.
24. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A. Elevation of blood (1->3)-beta-D-glucan concentrations in hemodialysis patients. Nephron 2001; 89:15-9.
25. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1->3)-beta-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 2006; 50:3450-3.
26. Kumar A, Roberts D, Wood K, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Med 2006; 34:1589-96.
27. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-35.
28. Brion LP, Uko SE, Goldman DL. Risk of resistance associated with fluconazole prophylaxis: systematic review. J Infect 2007; 54:521-9.
29. Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC. Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care 2011; 15:R198.